Hypoglycemia Clinical Trial
Official title:
Hypoglycemia in Prader-Willi Syndrome: A Prospective Study
This project will study whether infants with Prader-Willi Syndrome experience low blood sugars after short periods of fasting. This study will also evaluate metabolic markers in the blood to determine if infants with Prader-Willi Syndrome process energy differently than other children during fasting.
This study will include outpatient admission to the clinical research center for IV
placement, blood draws from the IV, poking the participants finger to obtain small amounts
of blood and monitored 6 hour fast. A fast is when a person goes without food for a certain
period of time. The participant will not be fasted longer than 6 hours.
The participant will arrive to the outpatient clinical research center at approximately 7am.
A parent will be expected to stay with the participant at all times. The participant's
finger will be poked for blood (requires approximately one drop of blood) soon after arrival
to make sure his blood sugar is not already low. If the participant's blood sugar is low on
arrival to the Clinical Research Center, additional blood will be drawn through his vein (a
little more than half a teaspoon) and he will not have to complete the rest of the study. If
his blood glucose is above 60 mg/dl, the participant will be given an opportunity to eat
prior to starting the fast. A small tube will be placed in the participant's vein at the
beginning of the fast to make additional blood draws easier. 1/10th a teaspoon of blood will
be sent for cortisol testing when the IV is placed. Cortisol is a hormone that is important
for control of blood sugar. In addition, the participant's finger will be pricked every hour
for blood to monitor his blood sugar by bedside meter. Each finger prick will require
approximately one to two drops of blood. A test to look at fat breakdown (ketones) will
sometimes be checked using the same blood obtained when pricking the finger to check blood
sugar. If a blood sugar of less than 70 mg/dl is found, blood sugars will be checked by
finger prick every 30 minutes instead of every hour. If finger prick blood glucose is less
than 65 mg/dl, blood will be collected and sent to the clinical research center lab to make
sure that the true blood sugar reading is not lower than what is seen on the bedside meter
(requires approximately 1/10 teaspoon of blood). If a blood sugar of less than 60 mg/dl is
found, the fast will end and blood will be collected through the IV line (small tube placed
through the vein). The participant will be monitored by a nurse during the fast. She will
check his blood pressure, pulse and respiratory rate periodically to make sure he is
comfortable. After final blood collection, the participant will be allowed to feed normally
and his IV will be removed. During the entire study, we expect to collect at least ¾ of a
teaspoon of blood from the participant. No more than 1.2 teaspoons of blood will be
collected from the participant during this entire study.
If a blood sugar less than 60 mg/dl is found at any time, blood will be drawn from a vein in
the participant's arm and the study will end. He will then be allowed to eat. If he has a
low blood sugar and is unable to feed the way he normally does, sugar water/gel may be given
by mouth or sugar water may be given by the tube placed in his vein. If the participant
normally is fed by a tube placed in his stomach, sugar water may be given through this tube.
;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03482154 -
Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population
|
||
Completed |
NCT03667053 -
Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children
|
Phase 3 | |
Active, not recruiting |
NCT03422471 -
Hypoglycemia and Autonomic Nervous System Function- B2
|
N/A | |
Recruiting |
NCT05379686 -
Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes
|
N/A | |
Completed |
NCT05597605 -
The SHINE Study: Safety of Implant and Preliminary Performance of the SHINE SYSTEM in Diabetic Subjects
|
N/A | |
Not yet recruiting |
NCT05990933 -
Role of Adrenaline in in the Inflammatory Response in Diabetes
|
N/A | |
Withdrawn |
NCT03736083 -
Introducing CGM at Type 1 Diabetes Diagnosis
|
N/A | |
Completed |
NCT02966275 -
Post Bariatric Closed Loop Glucagon Trial
|
N/A | |
Not yet recruiting |
NCT02909881 -
Dose Response Oxidation of a Sweet-corn Derived Sugar (PhytoSpherix) During Exercise in Endurance Trained Athletes
|
N/A | |
Withdrawn |
NCT02518022 -
How to be Safe With Alcoholic Drinks in Diabetes
|
N/A | |
Completed |
NCT02213003 -
Allogeneic Islet Cells Transplanted Onto the Omentum
|
Phase 1/Phase 2 | |
Completed |
NCT01147276 -
Vildagliptin and the Glucagon Response to Hypoglycemia in Type 1 Diabetes
|
Phase 4 | |
Completed |
NCT01176656 -
Hypoglycemia: Physician and Patient Perspectives
|
N/A | |
Completed |
NCT00998374 -
Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge
|
N/A | |
Terminated |
NCT01225159 -
Tight Glycaemic Control During Cardiac Surgery
|
N/A | |
Completed |
NCT00373854 -
Study of How Low Blood Sugar Affects the Way Blood Vessels Work
|
N/A | |
Completed |
NCT00285233 -
Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes
|
Phase 1/Phase 2 | |
Recruiting |
NCT05916131 -
Pilot Feasibility Study for HypoPals, a Mobile Health Program for Improving Hypoglycemia Management.
|
N/A | |
Terminated |
NCT04026750 -
Insulin Tolerance Test Study in Patients With Type 1 Diabetes
|
Phase 1 | |
Completed |
NCT05133765 -
The SMART B Exercise Study :''The SMART Study''
|
N/A |